维普中文期刊产品整合服务
143篇 您的检索式:作者名="Oriuchi"
    题名 作者 年代 出处 被引量
1肿瘤患者脑局部葡萄糖代谢变化的SPM分析显示文摘目的 用1 8F 脱氧葡萄糖 (1 8F FDG)PET显像和SPM软件研究分析肿瘤患者脑局部葡萄糖代谢的变化。方法 研究对象为 2 0例确诊为无脑疾患的恶性肿瘤患者和 2 0例健康志愿者。1 8F FDG PET显像后 ,用统计参数显像 (SPM)法比较分析肿瘤患者和健康志愿者脑葡萄糖代谢的差别。结果 SPM分析显示肿瘤患者的的脑岛、松果体、顶叶皮质、小脑蚓部、颞叶和前额叶都表现为不同程度的葡萄糖代谢低下。结论 肿瘤病人的抑郁表现与脑葡萄糖代谢降低相关 ,SPM方法是一种客观和直观的分析脑功能性变化的工具。袁志斌 Matsubara K Higuchi T Oriuchi N Endo K 2004中国医学影像技术2004,20,3:4
2Evaluation of 18F-2-deoxy-2-fluoro-d-glucose Positron Emission Tomography for Gastric Cancer显示文摘Erito Mochiki Hiroyuki Kuwano Hiroyuki Katoh Takayuki Asao Noboru Oriuchi Keigo Endo 2004World Journal of Surgery2004,,3:2
3Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer显示文摘Kaira K Oriuchi N Shimizu K 2009Cancer Sci2009,100,4:1
4Usefulness of FDG- PET for early prediction of the response to gefitinib in non-small cell lung cancer显示文摘Sunaga N Oriuchi N Kaira K 2008Lung Cancer2008,59,2:1
511C -choline PET for detection of bone and soft tissue tumors in comparison with 18F-FDG PET 显示文摘Zhang H Tian M Oriuchi N 2003Nucl Med Commun2003,24,4:1
6L-type amino acid transporter 1 ex- pression is a proguostic marker in patients with surgically resected stage I non-small cell lung cancer 显示文摘Imai H Kalra K Oriuchi N 2009Histopathology2009,54,7:1
7Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer显示文摘hnai H Kaira K Oriuchi N 2010Anticancer Res2010,30,12:1
8Prognostic significanceof L-type amino acid transporter 1 (LAT1) and 4F2 heavychain (CD98) expression in stage I pulmonaryadenocarcinoma显示文摘Kaira K Oriuchi N Imai H 2009Lung Cancer2009,66,1:1
9Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the iung显示文摘Kaira K Oriuchi N Imai H 2008Pathol Res Pract2008,204,8:1
10L-type amino acid transport er 1 and CD98 expression in primary and metastatic sites of hu manneoplasms显示文摘Kaira K Oriuchi N Imai H 2008CancerSci2008,99,12:1
11^11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET显示文摘Zhang H Tian M Oriuchi N 2003Nucl Med Commun2003,24,3:1
12Usefulness of FDG- PET for early prediction of the response to gefitinib in non-small cell lung cancer显示文摘Sunaga N Oriuchi N Kaira K 2007Lung Cancer2007,1,:1
1311C-choline PET for the detection of bone and soft tissue tumors in comparison with FDG PET显示文摘ZHANG H TIAN M ORIUCHI N 0,,03:1
14Prognostic significance of L-type amino acid transporter 1(LAT1)and 4F2 heavy chain(CD98)expression in stage I pulmonary adenocarcinoma显示文摘KAIRA K ORIUCHI N IMAI H 2009Lung Can-cer2009,66,1:1
15L-type amino acid transporter I (LATl)is frequently expressed in thymic carcinomas but is absent in thymomas显示文摘Kaira K Oriuchi N Imai H 2009J Surg Oncol2009,99,7:1
16Correlation of angiogene- sis with ISF-FMT and 18F-FDG uptake in non-small cell lung cancer 显示文摘Kaira K Oriuchi N Shimizu K 2009Cancer Sci2009,100,4:1
17L-type amino acid transporter I expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer显示文摘Imai H Kaira K Oriuchi N 2009Histopathology2009,54,7:1
18The role of whole body FDG-PET in preoperative assessment of tumor staging in oral cancers 显示文摘NA KASONE Y INOUE T ORIUCHI N 2001Ann Nucl Med2001,15,:1
19Expression of L-type amino acid transporter I (LATl)in neuroendocrine tumors of the lung显示文摘Kaira K Oriuchi N Imai H 2008Pathol Res Pract2008,204,8:1
20CD98 expression isassociated with poor prognosis in resected non-small-celllung cancer with lymph node metastases显示文摘Kaira K Oriuchi N Imai H 2009Ann SurgOncol2009,16,12:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费